Security key
457637601
InMed Pharmaceuticals Inc. - Common Shares, no par value (INM)
CUSIP: 457637601
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 100,918
- Total 13F value
- $109,292
- Share change
- -14,910
- SEC-reported price per share
- $1.08
- Number of holders
- 12
- Value change
- -$123,996
- Number of buys
- 6
- Number of sells
- 3
- Shares outstanding
- 804,525
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
12
Top holders
10
INM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Previous quarter: Q4 2022
InMed Pharmaceuticals Inc. SEC filings
InMed Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 457637601
Recent filing periods:
Ownership snapshot
Top reported holders of INM - InMed Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
12/15
Latest evidence
31 Dec 2022
13F
3/4/5
Lead comparable stake: 12%
3 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 12%.
12 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
12%
Virtu Financial LLC
2.2%
UBS Group AG
0.1%
TD Waterhouse Canada Inc.
0.01%
BlackRock Finance, Inc.
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
12%
|
$196,269
97,163 shares
|
— | 31 Dec 2022 |
| Virtu Financial LLC |
13F
Company
|
2.2%
|
$36,000
17,724 shares
|
— | 31 Dec 2022 |
| UBS Group AG |
13F
Company
|
0.1%
|
$1,679
831 shares
|
— | 31 Dec 2022 |
| TD Waterhouse Canada Inc. |
13F
Company
|
0.01%
|
$252
85 shares
|
— | 31 Dec 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
0.01%
|
$101
50 shares
|
— | 31 Dec 2022 |
| AllSquare Wealth Management LLC |
13F
Company
|
0%
|
$42
21 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
12
Shares
100,918
Rows available
12
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
11
Q1 2023 holders
12
Holder diff
1
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend